hydrochloride hydrate

The methylation of lysine residues on histones plays a central role in determining euchromatin structure and gene expression. The histone methyltransferase (HMTase) G9a can mono- or dimethylate lysine 9 on histone 3 (H3), contributing to early embryogenesis, genomic imprinting, and lymphocyte development. BIX01294 (hydrochloride hydrate) is a selective inhibitor of G9a HMTase (IC50 = 1.7 μM). It less effectively inhibits the HMTase G9a-like protein (GLP; IC50 = 38 μM) and has no effect on other known HMTases. BIX01294 has been used in combination with the calcium channel activator BayK8644 to facilitate the generation of induced pluripotent stem cells from somatic cells in vitro.

Zoniporide hydrochloride hydrate is a potent and selective sodium-hydrogen exchanger type 1 (NHE-1) inhibitor. Zoniporide hydrochloride hydrate inhibits human NHE-1 with IC50 of 14 nM.

D-Histidine hydrochloride hydrate is an agent that targets bacterial quorum sensing systems, such as the RhlI/RhlR pathway, to inhibit biofilm formation with antibacterial properties. It acts by non-covalently binding to bacterial regulatory factors or copper ion complexes, selectively inhibiting bacterial biofilm formation and motility. Additionally, D-Histidine hydrochloride hydrate downregulates quorum sensing-related gene expression, reduces synthesis of virulence factors (such as alginate and protease), and disrupts bacterial membrane stability. This results in inhibiting biofilm formation, promoting the disassembly of mature biofilms, and increasing antibiotic sensitivity. Furthermore, it serves as an efficient catalyst for the salt-induced peptide formation (SIPF) reaction by forming complexes with copper ions (Cu2+), which facilitates the condensation of amino acids to form dipeptides, such as di-alanine and di-lysine.

NG 25 is a type II kinase inhibitor that inhibits MAP4K2 and TAK1 (IC50s = 21.7 and 149 nM, respectively).1It also inhibits the Src family kinases Src and LYN (IC50s = 113 and 12.9 nM, respectively) and Abl family kinases (IC50s = 75.2 nM), as well as CSK, FER, and p38α (IC50s = 56.4, 82.3, and 102 nM, respectively). NG 25 (100 nM) prevents TNF-α-induced IKKα/β phosphorylation and IκB-α degradation in L929 cells. It inhibits secretion of IFN-α and IFN-β induced by CpG type B and CL097, respectively, in Gen2.2 cells in a concentration-dependent manner.2NG 25 decreases cell viability of HCT116KRASWT, and to a greater degree of HCT116KRASG13D, colorectal cancer cells in a concentration-dependent manner.3It also reduces tumor growth and increases the number of TUNEL-positive tumor cells in a CT26KRASG12Dmouse orthotopic model of colorectal cancer. 1.Tan, L., Nomanbhoy, T., Gurbani, D., et al.Discovery of type II inhibitors of TGFβ-activated kinase 1 (TAK1) and mitogen-activated protein kinase kinase kinase kinase 2 (MAP4K2)J. Med. Chem.58(1)183-196(2015) 2.Pauls, E., Shpiro, N., Peggie, M., et al.Essential role for IKKβ in production of type 1 interferons by plasmacytoid dendritic cellsJ. Biol. Chem. 287(23)19216-19228(2012) 3.Ma, Q., Gu, L., Liao, S., et al.NG25, a novel inhibitor of TAK1, suppresses KRAS-mutant colorectal cancer growth in vitro and in vivoApoptosis24(1-2)83-94(2019)

A-943931 is a histamine H4receptor antagonist (Ki= 3.8 nM).1In vivo, A-943931 inhibits scratching induced by clobenpropit in mice (ED50= 26 μmoles/kg, i.p.). 1.Milicic, I., Witte, D.G., Miller, T.L., et al.Identification of two potent and selective histamine H4 receptor antagonists with antipruritic activityFASEB J.23(S1)760.768-760.768(2009)

CDK7-IN-2 hydrochloride hydrate (Example 6) is a potent and specific inhibitor of the CDK7 enzyme, exhibiting significant anti-cancer properties.

Bepridil hydrochloride hydrate ((±)-Bepridil hydrochloride hydrate) is a long-acting, non-selective calcium channel (Ca+ channel) antagonist, an inhibitor of the Na+, K+ channel, and an inhibitor of cardiac Na+/Ca2+ exchange (NCX1).

Tiagabine hydrochloride hydrate is a potent and selective inhibitor of GABA uptake, inhibiting [3H] GABA uptake in synaptosomes, neurons, and glia with IC50 values of 67, 446, and 182 nM, respectively. This hydrate can be used as an anticonvulsant.

Topotecan hydrochloride hydrate is an orally active Topoisomerase I inhibitor with anticancer properties capable of blocking the cell cycle in the G0/G1 and S phases and inducing apoptosis.

CX-6258 hydrochloride hydrate is a potent, selective inhibitor of pan-Pim kinase, targeting Pim-1 (IC50: 5 nM), Pim-2 (IC50: 25 nM), and Pim-3 (IC50: 16 nM).

Samuraciclib (CT7001) hydrochloride hydrate is a potent, selective, ATP-competitive, orally active inhibitor of CDK7 (IC50: 41 nM). It inhibits the growth of breast cancer cell lines (GI50: 0.2-0.3 μM) and exhibits potent antitumor effects.

LP 12 hydrochloride hydrate is a selective and potent agonist at the 5-HT7 receptor (Ki: 0.13 nM) and is more selective for the 5-HT7 receptor than the D2 receptor (Ki: 224 nM), 5-HT1A receptor (Ki: 60.9 nM), and 5-HT2A receptor (Ki: >1000 nM).

Valacyclovir hydrochloride hydrate is a potent antiviral agent and prodrug rapidly converted to acyclovir in vivo, used to formulate ocular inserts for treating ocular herpes, and for the treatment of herpes simplex, herpes zoster, and herpes b.

N2-Boc-L-arginine Hydrochloride Hydrate is a useful organic compound for research related to life sciences. The catalog number is T65690 and the CAS number is 114622-81-0.

(S)-2-Amino-3-mercaptopropanoic acid hydrochloride hydrate is a useful organic compound for research related to life sciences. The catalog number is T66658 and the CAS number is 207121-46-8.

Zimeldine hydrochloride hydrate is a serotonin uptake inhibitor that was formerly used for depression but was withdrawn worldwide in September 1983 because of the risk of Guillain-Barre Syndrome associated with its use.

Iptacopan hydrochloride hydrate is a highly potent and highly selective factor B inhibitor.

Fasudil hydrochloride hydrate is an HCl salt of Fasudil -- a Rho-kinase (ROCK) inhibitor that has been shown to be effective in hindering the development of mature Cerebral Cavernous Malformation (CCM) lesions as well as reducing portal venous pressure in cirrhotic rats.

PKRA83 hydrochloride hydrate, also known as PKRA7, is a potent prokineticin (PK2) antagonist that competes with PK2 for binding to its receptors, PKR1 and PKR2. It exhibits high inhibitory affinity with IC50 values of 5.0 nM for PKR1 and 8.2 nM for PKR2, displaying anticancer, anti-arthritis, and anti-angiogenic properties. Additionally, this compound is capable of crossing the blood-brain barrier [1] [2] [3].

MCI-225 is a norepinephrine reuptake/5-HT3/5-HT reuptake inhibitor. MCI-225 could be effective in the treatment of senile dementia of the Alzheimer type, which is accompanied with both deficit in the BF-cortex cholinergic neuron and cerebral glucose hypom

Fedratinib hydrochloride hydrate (SAR 302503 hydrochloride hydrate) is a potent, selective, ATP-competitive and orally active JAK2 inhibitor.

p-NH2-Bn-NOTA (hydrochloride hydrate) is a bifunctional chelator (BFC) and a macrocyclic NOTA derivative utilized for tumor pre-targeting. It can be employed for conjugation with peptides and radionuclides.

TETA hydrochloride hydrate is an effective and selective chelating agent for copper (II). It can be utilized in drug conjugation.

p-NH2-CHX-A"-DTPA (hydrochloride hydrate) is a bifunctional chelator (Bifunctional Chelator; BFC) and macrocyclic DTPA derivative designed for tumor pre-targeting. It is suitable for conjugation with peptides and radionuclides.